Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$228K Buy
1,990
+11
+0.6% +$1.22K 0.11% 203
2025
Q4
$218K Buy
1,979
+7
+0.4% +$771 0.11% 190
2025
Q3
$220K Buy
+1,972
New +$207K 0.11% 173
2025
Q2
Sell
-1,958
Closed -$218K 201
2025
Q1
$218K Buy
1,958
+6
+0.3% +$636 0.13% 165
2024
Q4
$205K Buy
+1,952
New +$213K 0.12% 166
2021
Q1
Sell
-8,805
Closed -$391K 144
2020
Q4
$391K Sell
8,805
-745
-8% -$30.5K 0.33% 95
2020
Q3
$347K Sell
9,550
-1,635
-15% -$59.5K 0.36% 91
2020
Q2
$402K Sell
11,185
-225
-2% -$8.13K 0.43% 82
2020
Q1
$391K Buy
+11,410
New +$521K 0.46% 71

Other funds holding AFL

Capital Square's AFL Position: Q1 2026 in Review

Capital Square increased its Aflac (AFL) stake by 0.56% in Q1 2026, buying an estimated $1.22K and bringing the position to 1,990 shares worth $228K. The position accounts for 0.11% of the portfolio, ranked #203.

Capital Square first reported a position in AFL in Q1 2020 and has held it in 9 quarters since. The position peaked at $402K in Q2 2020. 1,654 funds tracked by Wall St. Rank hold AFL as of Q1 2026.

  • Capital Square held 1,990 shares of Aflac worth $228K as of Q1 2026.
  • Capital Square bought 11 Aflac shares in Q1 2026, an estimated $1.22K.
  • Aflac made up 0.11% of Capital Square's portfolio in Q1 2026, its #203 holding.
  • Capital Square first reported a position in Aflac in Q1 2020 and has held it in 9 quarters since.
  • Capital Square's Aflac position peaked at $402K in Q2 2020.
  • 1,654 funds tracked by Wall St. Rank held Aflac as of Q1 2026.

Based on Capital Square's 13F filing for Q1 2026, filed 11 May 2026.